Literature DB >> 19304959

PTPmu suppresses glioma cell migration and dispersal.

Adam M Burgoyne1, Juan M Palomo, Polly J Phillips-Mason, Susan M Burden-Gulley, Denice L Major, Anita Zaremba, Shenandoah Robinson, Andrew E Sloan, Michael A Vogelbaum, Robert H Miller, Susann M Brady-Kalnay.   

Abstract

The cell-surface receptor protein tyrosine phosphatase mu (PTPmu) is a homophilic cell adhesion molecule expressed in CNS neurons and glia. Glioblastomas (GBMs) are the highest grade of primary brain tumors with astrocytic similarity and are characterized by marked dispersal of tumor cells. PTPmu expression was examined in human GBM, low-grade astrocytoma, and normal brain tissue. These studies revealed a striking loss of PTPmu protein expression in highly dispersive GBMs compared to less dispersive low-grade astrocytomas and normal brain. We hypothesized that PTPmu contributes to contact inhibition of glial cell migration by transducing signals in response to cell adhesion. Therefore, loss of PTPmu may contribute to the extensive dispersal of GBMs. The migration of brain tumor cells was assessed in vitro using a scratch wound assay. Parental U-87 MG cells express PTPmu and exhibited limited migration. However, short-hairpin RNA (shRNA)-mediated knockdown of PTPmu induced a morphological change and increased migration. Next, a brain slice assay replicating the three-dimensional environment of the brain was used. To assess migration, labeled U-87 MG glioma cells were injected into adult rat brain slices, and their movement was followed over time. Parental U-87 MG cells demonstrated limited dispersal in this assay. However, PTPmu shRNA induced migration and dispersal of U-87 MG cells in the brain slice. Finally, in a mouse xenograft model of intracranially injected U-87 MG cells, PTPmu shRNA induced morphological heterogeneity in these xenografts. Together, these data suggest that loss of PTPmu in human GBMs contributes to tumor cell migration and dispersal, implicating loss of PTPmu in glioma progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19304959      PMCID: PMC2802397          DOI: 10.1215/15228517-2009-019

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  47 in total

Review 1.  Cell migration: Rho GTPases lead the way.

Authors:  Myrto Raftopoulou; Alan Hall
Journal:  Dev Biol       Date:  2004-01-01       Impact factor: 3.582

2.  A novel protein-tyrosine phosphatase related to the homotypically adhering kappa and mu receptors.

Authors:  J Cheng; K Wu; M Armanini; N O'Rourke; D Dowbenko; L A Lasky
Journal:  J Biol Chem       Date:  1997-03-14       Impact factor: 5.157

3.  Receptor tyrosine phosphatase R-PTP-kappa mediates homophilic binding.

Authors:  J Sap; Y P Jiang; D Friedlander; M Grumet; J Schlessinger
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

4.  Identification of the homophilic binding site of the receptor protein tyrosine phosphatase PTP mu.

Authors:  S M Brady-Kalnay; N K Tonks
Journal:  J Biol Chem       Date:  1994-11-11       Impact factor: 5.157

5.  Purification and characterization of the human protein tyrosine phosphatase, PTP mu, from a baculovirus expression system.

Authors:  S M Brady-Kalnay; N K Tonks
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

Review 6.  Rho GTPases: potential candidates for anticancer therapy.

Authors:  Salvador Aznar; Pilar Fernández-Valerón; Carolina Espina; Juan Carlos Lacal
Journal:  Cancer Lett       Date:  2004-04-08       Impact factor: 8.679

7.  A third-generation lentivirus vector with a conditional packaging system.

Authors:  T Dull; R Zufferey; M Kelly; R J Mandel; M Nguyen; D Trono; L Naldini
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

8.  PTPmu regulates N-cadherin-dependent neurite outgrowth.

Authors:  S M Burden-Gulley; S M Brady-Kalnay
Journal:  J Cell Biol       Date:  1999-03-22       Impact factor: 10.539

9.  Dynamic interaction of PTPmu with multiple cadherins in vivo.

Authors:  S M Brady-Kalnay; T Mourton; J P Nixon; G E Pietz; M Kinch; H Chen; R Brackenbury; D L Rimm; R L Del Vecchio; N K Tonks
Journal:  J Cell Biol       Date:  1998-04-06       Impact factor: 10.539

10.  Cell surface expression of receptor protein tyrosine phosphatase RPTP mu is regulated by cell-cell contact.

Authors:  M F Gebbink; G C Zondag; G M Koningstein; E Feiken; R W Wubbolts; W H Moolenaar
Journal:  J Cell Biol       Date:  1995-10       Impact factor: 10.539

View more
  30 in total

Review 1.  Tumour suppressor function of protein tyrosine phosphatase receptor-T.

Authors:  Anthony Scott; Zhenghe Wang
Journal:  Biosci Rep       Date:  2011-10       Impact factor: 3.840

2.  Cancer-derived mutations in the fibronectin III repeats of PTPRT/PTPrho inhibit cell-cell aggregation.

Authors:  Peng Zhang; Scott Becka; Sonya E L Craig; David T Lodowski; Susann M Brady-Kalnay; Zhenghe Wang
Journal:  Cell Commun Adhes       Date:  2009-12

3.  Identification of phospholipase C gamma1 as a protein tyrosine phosphatase mu substrate that regulates cell migration.

Authors:  Polly J Phillips-Mason; Harpreet Kaur; Susan M Burden-Gulley; Sonya E L Craig; Susann M Brady-Kalnay
Journal:  J Cell Biochem       Date:  2011-01       Impact factor: 4.429

4.  Plasma miR-221/222 Family as Novel Descriptive and Prognostic Biomarkers for Glioma.

Authors:  Rui Zhang; Bo Pang; Tao Xin; Hua Guo; Yi Xing; Shangchen Xu; Bin Feng; Bin Liu; Qi Pang
Journal:  Mol Neurobiol       Date:  2015-01-31       Impact factor: 5.590

5.  Cadherin-11, a marker of the mesenchymal phenotype, regulates glioblastoma cell migration and survival in vivo.

Authors:  Harpreet Kaur; Polly J Phillips-Mason; Susan M Burden-Gulley; Amber E Kerstetter-Fogle; James P Basilion; Andrew E Sloan; Susann M Brady-Kalnay
Journal:  Mol Cancer Res       Date:  2012-01-20       Impact factor: 5.852

6.  A novel molecular diagnostic of glioblastomas: detection of an extracellular fragment of protein tyrosine phosphatase mu.

Authors:  Susan M Burden-Gulley; Theresa J Gates; Adam M Burgoyne; Jennifer L Cutter; David T Lodowski; Shenandoah Robinson; Andrew E Sloan; Robert H Miller; James P Basilion; Susann M Brady-Kalnay
Journal:  Neoplasia       Date:  2010-04       Impact factor: 5.715

7.  A protease storm cleaves a cell-cell adhesion molecule in cancer: multiple proteases converge to regulate PTPmu in glioma cells.

Authors:  Polly J Phillips-Mason; Sonya E L Craig; Susann M Brady-Kalnay
Journal:  J Cell Biochem       Date:  2014-09       Impact factor: 4.429

Review 8.  The impact of phosphatases on proliferative and survival signaling in cancer.

Authors:  Goutham Narla; Jaya Sangodkar; Christopher B Ryder
Journal:  Cell Mol Life Sci       Date:  2018-05-03       Impact factor: 9.261

9.  A prognostic signature of G(2) checkpoint function in melanoma cell lines.

Authors:  Bernard Omolo; Craig Carson; Haitao Chu; Yingchun Zhou; Dennis A Simpson; Jill E Hesse; Richard S Paules; Kristine C Nyhan; Joseph G Ibrahim; William K Kaufmann
Journal:  Cell Cycle       Date:  2013-03-01       Impact factor: 4.534

10.  Proteolytic cleavage of protein tyrosine phosphatase mu regulates glioblastoma cell migration.

Authors:  Adam M Burgoyne; Polly J Phillips-Mason; Susan M Burden-Gulley; Shenandoah Robinson; Andrew E Sloan; Robert H Miller; Susann M Brady-Kalnay
Journal:  Cancer Res       Date:  2009-08-18       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.